purifi
avian
infecti
bronchiti
viru
ibv
use
screen
random
phage
display
peptid
librari
fourth
pan
posit
phage
sequenc
character
phage
specif
inhibit
ibv
infect
hela
cell
block
ibv
haemagglutin
one
linear
peptid
gsh
hrh
vh
pfv
posit
phage
highest
neutral
titer
synthes
peptid
inhibit
ibv
infect
hela
well
result
may
contribut
develop
antivir
therapeut
ibv
studi
determin
viral
cell
interact
coronavirus
compris
genu
coronavirida
famili
larg
envelop
virus
singl
strand
positivesens
rna
genom
gener
coronavirus
caus
sever
respiratori
enter
diseas
domest
anim
mild
upper
respiratori
infect
human
howev
novel
member
sever
acut
respiratori
syndrom
associ
coronaviru
sarscov
recent
identifi
caus
sever
respiratori
diseas
human
coronavirus
divid
four
serolog
distinct
group
avian
infecti
bronchiti
viru
ibv
belong
group
iii
coronavirus
etiolog
agent
acut
highli
contagi
respiratori
diseas
chicken
ibv
endem
probabl
countri
rais
chicken
host
rang
consid
restrict
chicken
serotyp
vaccin
base
attenu
strain
may
provid
poor
crossprotect
therefor
identif
inhibitori
peptid
ibv
may
signific
ibv
infect
control
chicken
studi
determin
viral
cell
interact
ibv
less
readili
grow
cell
cultur
except
chicken
kidney
cell
chicken
embryo
kidney
cell
recent
found
ibv
strain
grow
effici
freshli
digest
hela
cell
provid
conveni
tool
studi
ibv
replic
vitro
present
studi
use
cell
model
identifi
peptid
could
inhibit
ibv
infect
pan
random
phage
peptid
librari
purifi
viru
attenu
ibv
strain
use
studi
ibv
propag
chicken
embryon
egg
allanto
fluid
harvest
h
infect
clarifi
centrifug
g
min
hitachi
supernat
filtersteril
store
use
viru
purif
perform
supernat
continu
sucros
gradient
centrifug
briefli
clarifi
infect
allanto
fluid
precipit
wv
peg
wv
nacl
overnight
centrifug
g
min
hitachi
pellet
suspend
centrifug
continu
sucros
gradient
wv
g
h
ultracentrifug
beckman
coulter
white
viru
band
collect
dialyz
h
pb
final
viru
suspens
aliquot
store
use
specif
peptid
obtain
pan
random
phage
peptid
librari
ph
phage
display
peptid
librari
kit
new
england
biolab
inc
ipswich
usa
purifi
ibv
accord
manufactur
instruct
briefli
abovepurifi
ibv
moll
ph
coat
microtit
plate
overnight
coat
well
block
block
buffer
contain
mgml
bsa
wash
plaqueform
unit
pfu
origin
librari
first
round
pan
pfu
follow
round
pan
pipet
onto
coat
well
specif
bound
phage
recov
elut
buffer
moll
glycinehcl
ph
mgml
bsa
immedi
neutral
moll
trishcl
ph
amplifi
earlylog
phase
host
bacteria
vigor
shake
h
phage
precipit
pegnacl
titrat
concentr
phage
util
next
pan
haemagglutinationinhibit
neutral
test
third
fourth
round
pan
elut
phage
screen
elisa
clone
sequenc
primer
recommend
manufactur
singl
phage
clone
randomli
pick
screen
specif
bind
ibv
convent
elisa
fourth
round
pan
briefli
twofold
serial
dilut
phage
moll
carbon
buffer
ph
coat
microtit
plate
overnight
block
h
block
buffer
contain
mgml
bsa
ibv
wash
buffer
mmoll
trishcl
ph
mmoll
nacl
vv
pipet
coat
well
incub
h
specif
bind
detect
rabbit
antiserum
ibv
prepar
lab
horseradishperoxidaseconjug
goat
antibodi
rabbit
igg
southern
biotechnolog
associ
inc
birmingham
usa
signal
develop
ad
tmb
substrat
score
posit
wherea
neg
phage
clone
gave
valu
posit
phage
taken
templat
sequenc
analysi
sequenc
primer
tca
tag
tta
gcg
taa
specif
phage
piii
gene
fuse
random
peptid
recommend
manufactur
sequenc
servic
provid
shanghai
sangon
biolog
engin
technolog
servic
co
ltd
shanghai
china
align
analysi
perform
use
blastn
http
wwwncbinlmnihgov
peptid
sequenc
convent
hi
test
perform
polystyren
plate
briefli
amplifi
phage
custom
synthes
peptid
ac
scientif
inc
xian
china
twofold
serial
dilut
pb
react
equal
amount
four
haemagglutin
unit
hau
ibv
pretreat
trypsin
h
fresh
chicken
erythrocyt
ad
incub
h
hi
titer
phage
read
avian
virus
newcastl
diseas
viru
ndv
subtyp
avian
influenza
viru
aiv
phage
encod
irrelev
peptid
use
evalu
nonspecif
bind
meanwhil
erythrocyt
phage
control
set
exclud
selfagglutin
well
ibv
inhibit
elut
phage
custom
synthes
peptid
ac
scientif
inc
xian
china
human
cell
line
hela
chines
center
tissu
cultur
collect
cctcc
gdc
test
accord
standard
protocol
briefli
twofold
serial
dilut
phage
incub
equal
amount
tcid
ibv
h
tissu
cultur
plate
five
well
dilut
ibvphag
mixtur
ad
equal
amount
freshli
trypsindispers
hela
cell
appropri
densiti
phage
display
irrelev
peptid
test
parallel
neg
control
cell
grown
dmem
fetal
calf
serum
optim
concentr
antibiot
cytopath
effect
cpe
record
inhibit
titer
calcul
accord
reedmuench
method
assay
repeat
least
three
time
independ
third
fourth
round
pan
clone
identifi
posit
clone
elisa
ten
fourth
round
pan
sequenc
align
produc
consensu
peptid
motif
histidinerich
structur
hxxh
x
repres
residu
fig
librari
pan
purifi
ibv
sequenc
recov
phage
fourth
round
pan
shown
consensu
element
bold
histidinerich
motif
hxxh
flexibl
residu
number
two
h
sequenc
phage
fourth
pan
detect
hi
test
hi
titer
rang
wherea
phage
unrel
peptid
could
inhibit
haemagglutin
ibv
tabl
sequenc
irrelev
peptid
agnlgplrssav
obtain
pan
anoth
protein
lab
contrast
recov
phage
could
inhibit
haemagglutin
ndv
aiv
two
linear
peptid
custom
synthes
peptid
phage
ngsh
hrh
vh
pfvc
peptid
made
accord
sequenc
felin
aminopeptidas
n
fapn
cellular
receptor
ibv
residu
nnyt
shq
ghm
valc
genbank
access
hi
test
show
neither
two
peptid
hi
activ
eight
phage
clone
repres
seven
sequenc
fourth
pan
test
viral
inhibit
activ
could
inhibit
ibv
infect
hela
concentr
phage
twofold
serial
dilut
start
correspond
pfu
h
distinct
cpe
occur
inhibit
titer
calcul
base
cpe
observ
infect
cell
becam
round
congreg
detach
cell
monolay
fig
eight
phage
clone
show
inhibit
titer
respect
phage
unrel
peptid
block
ibv
infect
two
synthet
peptid
peptid
could
inhibit
ibv
infect
hela
peptid
could
inhibit
titer
peptid
correspond
peptid
phage
display
wide
util
screen
antigen
epitop
monoclon
antibodi
studi
interact
virus
receptor
viru
surfac
glycoprotein
display
phage
often
use
pan
cell
screen
new
viru
receptor
function
domain
receptor
instanc
adenoviru
type
hepat
c
viru
hiv
rotaviru
etc
receptor
domain
display
phage
also
success
use
character
function
motif
viru
surfac
glycoprotein
coronavirus
phage
display
use
character
recombin
antiidiotyp
antibodi
murin
coronavirusneutr
monoclon
antibodi
murin
coronaviru
neutral
epitop
monoclon
antibodi
sarscov
current
studi
techniqu
appli
identifi
function
peptid
could
inhibit
viru
infect
cultur
cell
fourth
pan
histidinerich
structur
hxxh
found
exist
peptid
display
phage
fig
haemagglutin
relat
coronavirus
bind
sialic
acid
contain
receptor
erythrocyt
ibv
transmiss
gastroenter
viru
tgev
test
hi
activ
posit
phage
result
show
posit
phage
clone
display
seven
differ
peptid
sequenc
fourth
pan
could
specif
inhibit
haemagglutin
ibv
tabl
evid
suggest
peptid
might
block
sialic
acid
bind
site
ibv
spike
protein
therefor
inhibit
ibv
haemagglutin
demonstr
sialic
acid
bind
activ
tgev
correl
enteropathogen
tgev
ibv
similar
characterist
peptid
hi
activ
abl
inhibit
viru
infect
therefor
test
phage
possess
inhibitori
activ
ibv
infect
cell
human
cell
line
hela
select
host
cell
prove
freshli
digest
hela
cell
suscept
ibv
infect
fact
studi
also
perform
confirm
ibv
replic
hela
amplifi
gene
rtpcr
sequenc
gene
observ
viru
particl
electron
microscopi
data
shown
consequ
phage
differ
sequenc
fourth
pan
could
inhibit
ibv
infect
phage
unrel
peptid
possess
abil
confirm
function
peptid
synthes
peptid
peptid
phage
highest
neutral
titer
result
peptid
could
block
ibv
infect
hela
cell
although
could
inhibit
ibv
haemagglutin
isol
peptid
contain
aa
residu
would
possibl
hi
activ
phage
attribut
steric
hindranc
phage
although
hypothesi
may
borrow
support
evid
bind
site
cellular
receptor
porcin
aminopeptidas
n
sialic
acidcontain
receptor
erythrocyt
locat
differ
portion
protein
tgev
exact
mechan
remain
clarifi
report
ibv
could
use
felin
apn
cellular
receptor
explor
possibl
function
hxxh
structur
peptid
deriv
fapn
similar
structur
genbank
access
test
parallel
howev
peptid
could
inhibit
ibv
infect
hela
cell
natur
receptor
ibv
found
yet
signific
hxxh
peptid
relationship
inhibitori
peptid
ibv
natur
receptor
need
investig
conclus
identifi
peptid
inhibit
ibv
infect
cultur
cell
would
signific
ibv
infect
control
chicken
studi
determin
viru
cell
interact
